Gene Therapy 101 with Dr. Fred Askari

Dr. Fred Askari spoke in Session 2: The Future of Treatment for Wilson Disease
As Director of the Wilson Disease Center of Excellence at University of Michigan, Dr. Askari has seen and treated patients, and consults with physicians and patients from all parts of the world, advising on the latest advances in Wilson disease diagnosis and treatment. He is the author of the widely read and quoted, Hepatitis C, the Silent Epidemic, and has co-authored many manuscripts and journal articles. Dr. Askari is a member of the WDA Medical Advisory Committee (MAC). Dr. Askari earned his medical and doctorate degrees from Cornell University Medical College. He completed his fellowship in gastroenterology at the University of Michigan. His clinical and research interests encompass viral hepatitis, medical genetics, hepatology and liver transplantation. As an outgrowth of these interests, and his association with Dr. George Brewer, Dr. Askari became skilled in the study and treatment of Wilson disease. While previous WD clinical research focused on the neurological aspects of WD, Dr. Askari is concentrating on improving the diagnosis and treatment of hepatic Wilson patients.